PTAB challenges

Proceedings overview

There has been one AIA trial proceeding concerning US Patent 9591117. The proceeding, IPR2025-01426, was terminated, suggesting a settlement or joint request for adverse judgment rather than a final decision on the merits. This means the claims of the patent have not been substantively challenged and invalidated through the PTAB process, leaving the patent's claims untested by an IPR.

IPR2025-01426 — [Apple Inc.](/litigations/by-plaintiff/Apple%20Inc.) v. Garin Toren

• Type: Inter Partes Review
• Filed: 2025-08-29
• Status: Terminated (The proceeding concluded without a full merits decision, likely due to a settlement or other agreement between the parties.)
• Judge panel: Not publicly available from the provided data.
• Petition grounds: Not publicly available from the provided data.
• Institution decision: Not publicly available from the provided data.
• Final Written Decision (if issued): No Final Written Decision was issued as the proceeding was terminated.
• Settlement / termination: The proceeding was terminated on 2026-04-14. The specific terms of the termination are confidential, but IPRs are frequently terminated due to settlements between the petitioner and patent owner.
• Appeal: Not applicable, as no Final Written Decision was issued.
• Defensive value: The termination of this IPR means that the claims of US9591117 were not adjudicated by the PTAB. Therefore, this IPR does not offer a definitive ruling on the patentability of the claims for a defendant. The fact that the IPR was terminated by Apple Inc. could suggest a confidential settlement or licensing agreement, which might indicate that Apple found value or risk in the patent, leading them to resolve the dispute outside of a full PTAB decision.

Strategic summary

Currently, all claims of US9591117 remain UNTESTED by a PTAB Final Written Decision. The single IPR filed, IPR2025-01426, was terminated before a decision on the merits, likely due to a settlement between Apple Inc. (the petitioner) and the patent owner. This means there is no PTAB-based estoppel under § 315(e)(2) for this specific IPR, as no claims were found unpatentable in a final written decision. For a defendant currently being asserted against, all prior-art grounds remain available to challenge the patent's claims, provided those grounds meet the statutory requirements for an IPR or other relevant challenges. The termination of the IPR by Apple, a major technology company, might suggest a licensing agreement or other private resolution. This could be interpreted in different ways: either the patent owner successfully defended the claims, or Apple found it strategically advantageous to settle rather than risk a PTAB decision, or the claims were narrowed as part of the settlement.

Recommended next steps

Since no claims of US9591117 have been invalidated by the PTAB, there is no FWD to link to or disposition to quote. If you are a defendant facing assertion of this patent, you should consider a fresh analysis of the patent's claims against the prior art to identify potential grounds for a new IPR petition. The absence of an active PTAB challenge means the patent has not yet faced a public invalidity challenge that proceeded to a final decision.